{
    "organizations": [],
    "uuid": "d1b35757d0e6b9ae2a1901bcba3256bad191ef41",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/merck-co-results/merck-posts-bigger-quarterly-loss-idUSL4N1PS3YW",
    "ord_in_thread": 0,
    "title": "Merck posts bigger quarterly loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 2 (Reuters) - U.S. drugmaker Merck & Co Inc reported a bigger quarterly loss on Friday, partly due to a $2.6 billion charge related to recent changes to the U.S. tax law.\nThe company said its research and development expenses fell 56 percent to $2.06 billion in the quarter.\nMerckâ€™s net loss attributable widened to $872 million, or 32 cents per share, in the fourth quarter, from $594 million, or 22 cents per share, a year earlier. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)\n ",
    "published": "2018-02-02T19:57:00.000+02:00",
    "crawled": "2018-02-03T21:27:44.063+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "drugmaker",
        "merck",
        "co",
        "inc",
        "reported",
        "bigger",
        "quarterly",
        "loss",
        "friday",
        "partly",
        "due",
        "billion",
        "charge",
        "related",
        "recent",
        "change",
        "tax",
        "law",
        "company",
        "said",
        "research",
        "development",
        "expense",
        "fell",
        "percent",
        "billion",
        "quarter",
        "merck",
        "net",
        "loss",
        "attributable",
        "widened",
        "million",
        "cent",
        "per",
        "share",
        "fourth",
        "quarter",
        "million",
        "cent",
        "per",
        "share",
        "year",
        "earlier",
        "reporting",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ]
}